Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurochemistry International

• Publication date

  2002-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0197-0186(01)00133-4PMID 11900857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice

  2005cited by this paper
• Ibogaine alters synaptosomal and glial glutamate release and uptake

  2001cited by this paper
• Glutamate transporters in neurologic disease.

  2001cited by this paper
• Glutamate uptake.

  2001cited by this paper
• Kynurenines in the CNS: from endogenous obscurity to therapeutic importance.

  2001cited by this paper
• Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.

  2001cited by this paper
• Astrocyte glutamate transport: Review of properties, regulation, and physiological functions

  2000cited by this paper
• Guanosine and GMP prevent seizures induced by quinolinic acid in mice.

  2000cited by this paper
• Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain

  2000cited by this paper
• Synaptosomal glutamate release induced by the fraction Bc2 from the venom of the sea anemone Bunodosoma caissarum.

  1999cited by this paper
• New order from neurological disorders

  1999cited by this paper
• Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury.

  1999cited by this paper
• Glutamate receptors in the mammalian central nervous system.

  1998cited by this paper
• A presynaptic N‐methyl‐d‐aspartate autoreceptor in rat hippocampus modulating amino acid release from a cytoplasmic pool

  1998cited by this paper
• GMP protects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum.

  1997cited by this paper
• Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures.

  1997cited by this paper
• Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system.

  1997cited by this paper
• Neuronal Regulation of Glutamate Transporter Subtype Expression in Astrocytes

  1997cited by this paper
• Regulation of Glutamate Transport into Synaptic Vesicles by Chloride and Proton Gradient (*)

  1996cited by this paper
• Amino acid neurotransmission: Dynamics of vesicular uptake

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Excitatory amino acids as a final common pathway for neurologic disorders.

  1994cited by this paper
• Quinolinic acid in neurological disease: opportunities for novel drug discovery.

  1994cited by this paper
• Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

  1992cited by this paper
• Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

  1991cited by this paper
• Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension.

  1989cited by this paper
• A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions.

  1988cited by this paper
• Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo

  1988cited by this paper
• Effect of ouabain on norepinephrine-induced contractions of isolated rabbit aorta.

  1988cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Tryptophan-kynurenine metabolism: A link between the gut microbiota dysbiosis and cognitive impairment.

  2026cites this paper
• Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized Psychiatry.

  2026cites this paper
• Métabolisme du tryptophane : voie de la kynurénine

  2026cites this paper
• Quinolinic acid potentially links kidney injury to brain toxicity

  2025cites this paper
• Chronic stress and brain kynurenine pathway: addressing unresolved issues with a meta-analytic approach of preclinical studies, translational implication for psychiatric disorders.

  2025cites this paper
• Analysis of the Pro-Inflammatory Mechanisms of Gut Microbiota Metabolites in Inducing Alzheimer’s Disease

  2025cites this paper
• The interplay between metabolism and neuroinflammation in epilepsy: mechanisms and therapeutic perspectives

  2025cites this paper
• Tryptophan metabolism in migraine: a review of experimental and clinical studies and a need to enhance research strategies

  2025cites this paper
• Kynurenines and Mitochondrial Disturbances in Multiple Sclerosis

  2025cites this paper
• A zebrafish model of acmsd deficiency does not support a prominent role for ACMSD in Parkinson’s disease

  2025cites this paper
• Kynurenine pathway: a possible new mechanism for exercise in the prevention and treatment of Alzheimer's disease

  2025cites this paper
• Alterations in gut microbiota and plasma metabolites in patients with generalized anxiety disorder: a multi-omics study

  2025cites this paper
• Immunoexcitoxicity as the possible major pathophysiology behind multiple sclerosis and other autoimmune disorders

  2025cites this paper
• Neuropsychological and central neurologic effects of cancer immunotherapy: the start of a new challenge

  2025cites this paper
• Avocado Oil Prevents Neurological and Behavioral Alterations in a Quinolinic Acid-Induced Model of Huntington’s Disease

  2025cites this paper
• A history of suicide attempts among individuals with schizophrenia is associated with tryptophan degradation via the salivary kynurenine pathway

  2025cites this paper
• Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

  2024cites this paper
• Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

  2024cites this paper
• The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer’s Disease

  2024cites this paper
• Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond

  2024cites this paper
• Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses.

  2024cites this paper
• A Hypothesis: Metabolic Contributions to 16p11.2 Deletion Syndrome

  2024cites this paper
• Mechanism of N6-Methyladenosine Modification in the Pathogenesis of Depression

  2024cites this paper
• Association between Inflammatory and Metabolic Biomarkers and Common Mental Disorders among Adults: 2015 Health Survey of São Paulo, SP, Brazil

  2024cites this paper
• KYNA Ameliorates Glutamate Toxicity of HAND by Enhancing Glutamate Uptake in A2 Astrocytes

  2024cites this paper
• The dangerous "West Coast Swing" by hyperglycaemia and chronic stress in the mouse hippocampus: role of kynurenine catabolism.

  2024cites this paper
• The neuroimmune mechanism of pain induced depression in psoriatic arthritis and future directions.

  2024cites this paper
• The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy

  2024cites this paper
• Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia

  2024cites this paper
• Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment

  2024cites this paper
• Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases

  2023cites this paper
• Potential Plausible Role of Stem Cell for Treating Depressive Disorder: a Retrospective Review

  2023cites this paper
• Effects of different chronic restraint stress periods on anxiety- and depression-like behaviors and tryptophan-kynurenine metabolism along the brain-gut axis in C57BL/6N mice.

  2023cites this paper
• Epstein–Barr virus-acquired immunodeficiency in myalgic encephalomyelitis—Is it present in long COVID?

  2023cites this paper
• PTSD, Immune System, and Inflammation.

  2023cites this paper
• Relationship of tryptophan metabolites with the type and severity of multiple sclerosis.

  2023cites this paper
• How Oxidative Stress Induces Depression?

  2023cites this paper
• The kynurenine pathway in traumatic brain injuries and concussion

  2023cites this paper
• Inflammation, stress and depression: an exploration of ketamine's therapeutic profile.

  2023cites this paper
• Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

  2023cites this paper
• A unified model of the biology of peripartum depression

  2023cites this paper
• Stress and Kynurenine-Inflammation Pathway in Major Depressive Disorder.

  2023cites this paper
• Interferon therapy and its association with depressive disorders – A review

  2023cites this paper
• Early Life Stress, Neuroinflammation, and Psychiatric Illness of Adulthood.

  2023cites this paper
• Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response.

  2023cites this paper
• The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies

  2023cites this paper
• Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms

  2023cites this paper
• Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder

  2023cites this paper
• The Maternal Microbiome as a Map to Understanding the Impact of Prenatal Stress on Offspring Psychiatric Health.

  2023cites this paper
• Rat cortico-striatal sagittal organotypic slice cultures as ex vivo excitotoxic striatal lesion models

  2022cites this paper
• Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?—A Narrative Review

  2022cites this paper
• Pesticides Exposure-Induced Changes in Brain Metabolome: Implications in the Pathogenesis of Neurodegenerative Disorders

  2022cites this paper
• Interleukin-6 and tumor necrosis factor-α attenuate dopamine release in mice fed a high-fat diet, but not medium or low-fat diets

  2022cites this paper
• Co-occurrence of Fatigue and Depression in People With Multiple Sclerosis: A Mini-Review

  2022cites this paper
• Is (R)-ketamine a Potential Therapeutic Agent for Treatment-Resistant Depression with Less Detrimental Side Effects? A Review of Molecular Mechanisms Underlying Ketamine and its Enantiomers.

  2022cites this paper
• Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications.

  2022cites this paper
• Cytokine profile in drug-naïve panic disorder patients

  2022cites this paper
• Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease

  2022cites this paper
• IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's disease.

  2021cites this paper
• CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice

  2021cites this paper
• Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia

  2021cites this paper
• The role of microglia in chronic pain and depression: innocent bystander or culprit?

  2021cites this paper
• Predictive Genetic Variations in the Kynurenine Pathway for Interferon-α-Induced Depression in Patients with Hepatitis C Viral Infection

  2021cites this paper
• Main Biochemical Aspects of the Pathogenesis of Depression. Part II

  2021cites this paper
• Suicide as a Systemic Disorder

  2021cites this paper
• Excitotoxicity and the kynurenine pathway in multiple sclerosis

  2021cites this paper
• Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression

  2021cites this paper
• Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies

  2021influential citation
• Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity

  2021cites this paper
• [Prospects for the use of drugs with anti-inflammatory properties for the treatment of depression].

  2021cites this paper
• Caenorhabditis elegans as a model for studies on quinolinic acid-induced NMDAR-dependent glutamatergic disorders.

  2021cites this paper
• Changes in Gene Expression and Neuroinflammation in the Hippocampus after Focal Brain Ischemia: Involvement in the Long-Term Cognitive and Mental Disorders

  2021cites this paper
• Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period

  2021cites this paper
• Kynurenines and Neurofilament Light Chain in Multiple Sclerosis

  2021cites this paper
• Gut microbiota-derived vitamins - underrated powers of a multipotent ally in psychiatric health and disease.

  2021cites this paper
• Immunoregulation and antidepressant effect of ketamine

  2021cites this paper
• Изменение экспрессии генов и нейровоспаление в гиппокампе после фокальной ишемии мозга: участие в индукции длительных когнитивных и психоэмоциональных нарушений

  2021cites this paper
• From "Leaky Gut" to Impaired Glia-Neuron Communication in Depression.

  2020cites this paper
• Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression: A literature review

  2020cites this paper
• Tryptophan Metabolites Along the Microbiota-Gut-Brain Axis: An Interkingdom Communication System Influencing the Gut in Health and Disease

  2020cites this paper
• Inflammation as a treatment target in mood disorders: review

  2020cites this paper
• CAR T-Cell-Associated Neurotoxicity

  2020cites this paper
• Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling.

  2020cites this paper
• Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons

  2020cites this paper
• Insulin resistance and Alzheimer’s disease

  2020cites this paper
• Genetic Variations of Ionotropic Glutamate Receptor Pathways on Interferon-α-induced Depression in Patients with Hepatitis C Viral Infection.

  2020cites this paper
• Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms

  2020cites this paper
• The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder

  2020cites this paper
• The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

  2020cites this paper
• Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?

  2020cites this paper
• The Generalized Adaptation Account of Autism

  2020influential citation
• S-Allylcysteine Protects Against Excitotoxic Damage in Rat Cortical Slices Via Reduction of Oxidative Damage, Activation of Nrf2/ARE Binding, and BDNF Preservation

  2020cites this paper
• Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons

  2020cites this paper
• Microglia as therapeutic target in central nervous system disorders.

  2020cites this paper
• The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression

  2020cites this paper
• Hippocampal and Amygdalar Volume Changes in Major Depressive Disorder: A Targeted Review and Focus on Stress

  2020cites this paper
• Role of Inflammation in Depression and Treatment Implications.

  2019cites this paper
• Mood, immunity and brain connectivity in patients with chronic hepatitis c

  2019cites this paper
• The Role of Depressive Subtypes within the Neuroinflammation Hypothesis of Major Depressive Disorder.

  2019cites this paper
• Dietary fiber and its associations with depression and inflammation.

  2019cites this paper